Selection of Multi-Drug Targets against Drug-Resistant <i>Mycobacterium tuberculosis</i> XDR1219 Using the Hyperbolic Mapping of the Protein Interaction Network. [PDF]
Int J Mol Sci, 2023 Zahra NUA +3 more
europepmc +1 more source
Linezolid in the era of bedaquiline-pretomanid-linezolid-based regimens: an indispensable challenge. [PDF]
Respir Res Clin PractSantos AP, Mello FCQ.
europepmc +1 more source
Characterization of In Vitro Resistance to Linezolid in Mycobacterium abscessus. [PDF]
Microbiol Spectr, 2023 Negatu DA, Aragaw WW, Dartois V, Dick T.
europepmc +1 more source
Current and emerging therapies for pulmonary tuberculosis in adults. [PDF]
BMJ MedMahmood A +5 more
europepmc +1 more source
Improved Radiosynthesis of [<sup>18</sup>F]-Labeled Oxazolidinone Antibiotics for Future Clinical Translation. [PDF]
ACS Infect DisSarhan M +9 more
europepmc +1 more source
Next-Generation Diarylquinolines Improve Sterilizing Activity of Regimens with Pretomanid and the Novel Oxazolidinone TBI-223 in a Mouse Tuberculosis Model. [PDF]
Antimicrob Agents Chemother, 2023 Li SY +7 more
europepmc +1 more source
Triagem fenotípica da atividade antibacteriana de extratos naturais e compostos sintéticos
, 2019 Dissertação (mestrado) - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde, Programa de Pós-Graduação em Farmácia, Florianópolis, 2019.A resistência bacteriana representa uma crescente e preocupante ameaça à saúde pública em todo o ...
Costa, Giuliana Oliveira Ruas
core
New drugs for the management of tuberculosis. [PDF]
Curr Opin Infect DisCross GB.
europepmc +1 more source
Recent advances in tuberculosis treatment: Towards shorter, safer, and more effective therapies. [PDF]
J Clin Tuberc Other Mycobact DisTimboe K, Jackson JB, Becker GL.
europepmc +1 more source
In Vitro Activity of Oxazolidinone against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates. [PDF]
Antimicrob Agents Chemother, 2021 Kim DH, Kim SY, Koh WJ, Jhun BW.
europepmc +1 more source